Design Therapeutics, INC Form 4 insider transactions

Director Rodney W. Lappe acquired 19,000 stock options in Design Therapeutics, Inc. on June 13, 2024.

John P. Schmid, a director of Design Therapeutics, Inc., acquired stock options for 19,000 shares at an exercise price of $3.82 on June 13, 2024.

Heather A. Berger, a director of Design Therapeutics, Inc., acquired stock options for 19,000 shares of common stock on June 13, 2024.

Director Deepa Prasad acquired stock options for 19,000 shares of Design Therapeutics, Inc. at an exercise price of $3.82 on June 13, 2024.

Director John P. Schmid reports acquisition of Design Therapeutics shares through direct purchase and Schmid Family Trust.

Director Heather A. Berger purchased 1,300 shares of Design Therapeutics, Inc. on March 25, 2024.